537 related articles for article (PubMed ID: 31014193)
1. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
[TBL] [Abstract][Full Text] [Related]
2. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
[TBL] [Abstract][Full Text] [Related]
3. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
He L; Chen Z; Wang J; Feng H
BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
[TBL] [Abstract][Full Text] [Related]
4. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
[TBL] [Abstract][Full Text] [Related]
5. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
Wang X; Li M; Hu Y
Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
[TBL] [Abstract][Full Text] [Related]
6. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease.
Ke S; Yang Z; Yang F; Wang X; Tan J; Liao B
Yonsei Med J; 2019 Jul; 60(7):640-650. PubMed ID: 31250578
[TBL] [Abstract][Full Text] [Related]
8. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124.
Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W
Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528
[TBL] [Abstract][Full Text] [Related]
9. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1.
Li J; Wang H
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672
[TBL] [Abstract][Full Text] [Related]
10. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
Ge Y; Song X; Liu J; Liu C; Xu C
Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
Long JM; Ray B; Lahiri DK
J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
[TBL] [Abstract][Full Text] [Related]
12. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
Zhang J; Wang R
Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
[TBL] [Abstract][Full Text] [Related]
13. miR-186 is decreased in aged brain and suppresses BACE1 expression.
Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
[TBL] [Abstract][Full Text] [Related]
14. miR-124 Regulates the Expression of BACE1 in the Hippocampus Under Chronic Cerebral Hypoperfusion.
Zhang X; Huang X; Fang C; Li Q; Cui J; Sun J; Li L
Mol Neurobiol; 2017 May; 54(4):2498-2506. PubMed ID: 26984601
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA AXL increases neuron injury and inflammation through targeting microRNA-328 mediated BACE1 in Alzheimer's disease.
Li Y; Han X; Fan H; Sun J; Ni M; Zhang L; Fang F; Zhang W; Ma P
Neurosci Lett; 2022 Apr; 776():136531. PubMed ID: 35167942
[TBL] [Abstract][Full Text] [Related]
16. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
Zhang J; Hu M; Teng Z; Tang YP; Chen C
J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
[TBL] [Abstract][Full Text] [Related]
17. The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.
Fang M; Wang J; Zhang X; Geng Y; Hu Z; Rudd JA; Ling S; Chen W; Han S
Toxicol Lett; 2012 Feb; 209(1):94-105. PubMed ID: 22178568
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA BACE1-AS Modulates Isoflurane-Induced Neurotoxicity to Alzheimer's Disease Through Sponging miR-214-3p.
He W; Chi S; Jin X; Lu J; Zheng W; Yan J; Zhang D
Neurochem Res; 2020 Oct; 45(10):2324-2335. PubMed ID: 32681443
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1.
Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX
Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728
[TBL] [Abstract][Full Text] [Related]
20. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs.
Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H
J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
